Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	neurexin family protein binding	NLGN4Y SYTL2 NLGN1 NLGN4X NLGN2	2.33e-07	16	181	5	GO:0042043
GeneOntologyMolecularFunction	adenosine-phosphate deaminase activity	AMPD1 AMPD2 AMPD3	7.33e-07	3	181	3	GO:0047623
GeneOntologyMolecularFunction	AMP deaminase activity	AMPD1 AMPD2 AMPD3	7.33e-07	3	181	3	GO:0003876
GeneOntologyMolecularFunction	kinase activity	CDC42BPG IP6K3 MAP4K3 CDKL3 SRPK2 ERN2 TRIM24 MAP3K6 RPS6KC1 CKB MST1 CKM EPHA2 TBK1 MAP3K9 FGFR2 MAP4K2 ALPK2	2.09e-04	764	181	18	GO:0016301
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	CDC42BPG IP6K3 MAP4K3 CDKL3 OAS3 SRPK2 ERN2 TRIM24 MAP3K6 RPS6KC1 CKB MST1 CKM EPHA2 TBK1 MAP3K9 FGFR2 POLQ MAP4K2 ALPK2	3.43e-04	938	181	20	GO:0016772
GeneOntologyMolecularFunction	protein kinase activity	CDC42BPG MAP4K3 CDKL3 SRPK2 ERN2 TRIM24 MAP3K6 RPS6KC1 MST1 EPHA2 TBK1 MAP3K9 FGFR2 MAP4K2 ALPK2	3.87e-04	600	181	15	GO:0004672
GeneOntologyMolecularFunction	RNA polymerase I core binding	RRN3P2 RRN3	4.84e-04	4	181	2	GO:0001042
GeneOntologyMolecularFunction	protein serine kinase activity	CDC42BPG MAP4K3 CDKL3 SRPK2 ERN2 MAP3K6 RPS6KC1 TBK1 MAP3K9 MAP4K2 ALPK2	4.94e-04	363	181	11	GO:0106310
GeneOntologyMolecularFunction	ATP hydrolysis activity	SMARCA5 MYO5B VWA8 MYO9B DHX37 DDX42 MSH2 ABCA7 CHD6 ATP1A4 POLQ KIF1C	7.18e-04	441	181	12	GO:0016887
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	CDC42BPG IP6K3 MAP4K3 CDKL3 SRPK2 ERN2 TRIM24 MAP3K6 RPS6KC1 MST1 EPHA2 TBK1 MAP3K9 FGFR2 MAP4K2 ALPK2	7.53e-04	709	181	16	GO:0016773
GeneOntologyBiologicalProcess	presynaptic membrane assembly	NLGN4Y NLGN1 NLGN4X NLGN2	1.06e-06	10	177	4	GO:0097105
GeneOntologyBiologicalProcess	postsynaptic membrane assembly	NLGN4Y NLGN1 NLGN4X NLGN2	1.65e-06	11	177	4	GO:0097104
GeneOntologyBiologicalProcess	presynaptic membrane organization	NLGN4Y NLGN1 NLGN4X NLGN2	3.53e-06	13	177	4	GO:0097090
GeneOntologyBiologicalProcess	postsynaptic membrane organization	ZDHHC2 NLGN4Y NLGN1 NLGN4X FARP1 NLGN2	8.35e-06	56	177	6	GO:0001941
GeneOntologyBiologicalProcess	neuron cell-cell adhesion	NLGN4Y NLGN1 NLGN4X NLGN2	8.80e-06	16	177	4	GO:0007158
GeneOntologyBiologicalProcess	IMP salvage	AMPD1 AMPD2 AMPD3	5.02e-05	9	177	3	GO:0032264
GeneOntologyBiologicalProcess	positive regulation of prostaglandin-E synthase activity	ITGAM ITGB2	7.32e-05	2	177	2	GO:2000363
GeneOntologyBiologicalProcess	regulation of prostaglandin-E synthase activity	ITGAM ITGB2	7.32e-05	2	177	2	GO:2000361
GeneOntologyBiologicalProcess	positive regulation of embryonic development	WNT4 TENM4 PLCB1 TLE6	7.88e-05	27	177	4	GO:0040019
GeneOntologyBiologicalProcess	positive regulation of protein localization to membrane	ZDHHC2 MYO5B ITGAM ITGB2 FARP1 EPHA2 NLGN2	1.32e-04	130	177	7	GO:1905477
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN4Y NLGN4X NLGN2	2.71e-06	4	185	3	GO:0098983
GeneOntologyCellularComponent	integrin alphaM-beta2 complex	ITGAM ITGB2	7.79e-05	2	185	2	GO:0034688
GeneOntologyCellularComponent	inhibitory synapse	NLGN4Y NLGN1 NLGN4X NLGN2	1.55e-04	31	185	4	GO:0060077
GeneOntologyCellularComponent	protein complex involved in cell adhesion	NLGN1 ITGA1 ITGAD ITGAM ITGB2	1.75e-04	59	185	5	GO:0098636
GeneOntologyCellularComponent	integrin complex	ITGA1 ITGAD ITGAM ITGB2	1.76e-04	32	185	4	GO:0008305
GeneOntologyCellularComponent	symmetric synapse	NLGN4Y NLGN4X NLGN2	1.83e-04	13	185	3	GO:0032280
GeneOntologyCellularComponent	glycinergic synapse	NLGN4Y NLGN4X NLGN2	6.96e-04	20	185	3	GO:0098690
Domain	Nlgn	NLGN4Y NLGN1 NLGN4X NLGN2	4.05e-08	5	179	4	IPR000460
Domain	AMPD	AMPD1 AMPD2 AMPD3	8.66e-07	3	179	3	IPR006329
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	3.44e-06	4	179	3	IPR029423
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	3.44e-06	4	179	3	PF14914
Domain	LRRC37_N	LRRC37A3 LRRC37A2 LRRC37A	3.44e-06	4	179	3	IPR032754
Domain	LRRC37	LRRC37A3 LRRC37A2 LRRC37A	3.44e-06	4	179	3	PF15779
Domain	A/AMP_deam_AS	AMPD1 AMPD2 AMPD3	3.44e-06	4	179	3	IPR006650
Domain	LRRC37A/B-like	LRRC37A3 LRRC37A2 LRRC37A	3.44e-06	4	179	3	IPR015753
Domain	Carboxylesterase_B_CS	NLGN4Y NLGN1 NLGN4X NLGN2	5.45e-06	13	179	4	IPR019819
Domain	CARBOXYLESTERASE_B_2	NLGN4Y NLGN1 NLGN4X NLGN2	7.58e-06	14	179	4	PS00941
Domain	COesterase	NLGN4Y NLGN1 NLGN4X NLGN2	7.58e-06	14	179	4	PF00135
Domain	CarbesteraseB	NLGN4Y NLGN1 NLGN4X NLGN2	7.58e-06	14	179	4	IPR002018
Domain	A_DEAMINASE	AMPD1 AMPD2 AMPD3	1.70e-05	6	179	3	PS00485
Domain	A_deaminase	AMPD1 AMPD2 AMPD3	1.70e-05	6	179	3	PF00962
Domain	A/AMP_deaminase_dom	AMPD1 AMPD2 AMPD3	1.70e-05	6	179	3	IPR001365
Domain	Integrin_dom	ITGA1 ITGAD ITGAM ITGB2	8.82e-05	25	179	4	IPR032695
Domain	NLGN4	NLGN4Y NLGN4X	9.13e-05	2	179	2	IPR030025
Domain	GREB1	GREB1L GREB1	9.13e-05	2	179	2	PF15782
Domain	GREB1	GREB1L GREB1	9.13e-05	2	179	2	IPR028422
Domain	FAM21	WASHC2C WASHC2A	9.13e-05	2	179	2	IPR027308
Domain	Spy1	SPDYE2 SPDYE21 SPDYE16	1.35e-04	11	179	3	PF11357
Domain	Speedy	SPDYE2 SPDYE21 SPDYE16	1.35e-04	11	179	3	IPR020984
Domain	NHR2	RUNX1T1 CBFA2T3	2.72e-04	3	179	2	PF08788
Domain	CBFA2T1/2/3	RUNX1T1 CBFA2T3	2.72e-04	3	179	2	IPR013289
Domain	CAP-ZIP_m	WASHC2C WASHC2A	2.72e-04	3	179	2	PF15255
Domain	NHR2	RUNX1T1 CBFA2T3	2.72e-04	3	179	2	IPR014896
Domain	ALMS_motif	ALMS1 CEP295	2.72e-04	3	179	2	IPR029299
Domain	FAM21/CAPZIP	WASHC2C WASHC2A	2.72e-04	3	179	2	IPR029341
Domain	ALMS_motif	ALMS1 CEP295	2.72e-04	3	179	2	PF15309
Domain	CNH	CDC42BPG MAP4K3 MAP4K2	2.92e-04	14	179	3	SM00036
Domain	CNH	CDC42BPG MAP4K3 MAP4K2	3.62e-04	15	179	3	PF00780
Domain	CNH	CDC42BPG MAP4K3 MAP4K2	3.62e-04	15	179	3	PS50219
Domain	CNH_dom	CDC42BPG MAP4K3 MAP4K2	3.62e-04	15	179	3	IPR001180
Domain	Integrin_alpha_C_CS	ITGA1 ITGAD ITGAM	4.42e-04	16	179	3	IPR018184
Domain	ATP-gua_PtransN	CKB CKM	5.41e-04	4	179	2	PF02807
Domain	PHOSPHAGEN_KINASE	CKB CKM	5.41e-04	4	179	2	PS00112
Domain	ATP-gua_Ptrans	CKB CKM	5.41e-04	4	179	2	PF00217
Domain	-	CKB CKM	5.41e-04	4	179	2	1.10.135.10
Domain	COE	EBF2 EBF4	5.41e-04	4	179	2	PS01345
Domain	Transcription_factor_COE	EBF2 EBF4	5.41e-04	4	179	2	IPR003523
Domain	MAPKKKK	MAP4K3 MAP4K2	5.41e-04	4	179	2	IPR021160
Domain	ATP-guanido_PTrfase_N	CKB CKM	5.41e-04	4	179	2	IPR022413
Domain	ATP-guanido_PTrfase_AS	CKB CKM	5.41e-04	4	179	2	IPR022415
Domain	ATP-guanido_PTrfase_cat	CKB CKM	5.41e-04	4	179	2	IPR022414
Domain	COE_HLH	EBF2 EBF4	5.41e-04	4	179	2	IPR032201
Domain	COE_DBD	EBF2 EBF4	5.41e-04	4	179	2	IPR032200
Domain	Transcription_factor_COE_CS	EBF2 EBF4	5.41e-04	4	179	2	IPR018350
Domain	COE1_HLH	EBF2 EBF4	5.41e-04	4	179	2	PF16423
Domain	COE1_DBD	EBF2 EBF4	5.41e-04	4	179	2	PF16422
Domain	PHOSPHAGEN_KINASE_N	CKB CKM	5.41e-04	4	179	2	PS51509
Domain	PHOSPHAGEN_KINASE_C	CKB CKM	5.41e-04	4	179	2	PS51510
Domain	Helicase_C	SMARCA5 DHX37 DDX42 ZRANB3 CHD6 POLQ	5.79e-04	107	179	6	PF00271
Domain	HELICc	SMARCA5 DHX37 DDX42 ZRANB3 CHD6 POLQ	5.79e-04	107	179	6	SM00490
Domain	Helicase_C	SMARCA5 DHX37 DDX42 ZRANB3 CHD6 POLQ	6.08e-04	108	179	6	IPR001650
Domain	Integrin_alpha-2	ITGA1 ITGAD ITGAM	6.35e-04	18	179	3	IPR013649
Domain	INTEGRIN_ALPHA	ITGA1 ITGAD ITGAM	6.35e-04	18	179	3	PS00242
Domain	Integrin_alpha2	ITGA1 ITGAD ITGAM	6.35e-04	18	179	3	PF08441
Domain	Integrin_alpha	ITGA1 ITGAD ITGAM	6.35e-04	18	179	3	IPR000413
Domain	HELICASE_CTER	SMARCA5 DHX37 DDX42 ZRANB3 CHD6 POLQ	6.38e-04	109	179	6	PS51194
Domain	HELICASE_ATP_BIND_1	SMARCA5 DHX37 DDX42 ZRANB3 CHD6 POLQ	6.38e-04	109	179	6	PS51192
Domain	DEXDc	SMARCA5 DHX37 DDX42 ZRANB3 CHD6 POLQ	6.38e-04	109	179	6	SM00487
Domain	Helicase_ATP-bd	SMARCA5 DHX37 DDX42 ZRANB3 CHD6 POLQ	6.70e-04	110	179	6	IPR014001
Domain	Int_alpha	ITGA1 ITGAD ITGAM	7.49e-04	19	179	3	SM00191
Domain	Int_alpha_beta-p	ITGA1 ITGAD ITGAM	7.49e-04	19	179	3	IPR013519
Domain	FYrich_C	KMT2B KMT2C	8.96e-04	5	179	2	IPR003889
Domain	FYrich_N	KMT2B KMT2C	8.96e-04	5	179	2	IPR003888
Domain	FYRC	KMT2B KMT2C	8.96e-04	5	179	2	SM00542
Domain	FYRN	KMT2B KMT2C	8.96e-04	5	179	2	SM00541
Domain	TAFH	RUNX1T1 CBFA2T3	8.96e-04	5	179	2	SM00549
Domain	ATP-guanido_PTrfase	CKB CKM	8.96e-04	5	179	2	IPR000749
Domain	TAFH_NHR1	RUNX1T1 CBFA2T3	8.96e-04	5	179	2	IPR003894
Domain	TAFH	RUNX1T1 CBFA2T3	8.96e-04	5	179	2	PS51119
Domain	FYRN	KMT2B KMT2C	8.96e-04	5	179	2	PF05964
Domain	FYRC	KMT2B KMT2C	8.96e-04	5	179	2	PF05965
Domain	FYRC	KMT2B KMT2C	8.96e-04	5	179	2	PS51543
Domain	FYRN	KMT2B KMT2C	8.96e-04	5	179	2	PS51542
Domain	TAFH	RUNX1T1 CBFA2T3	8.96e-04	5	179	2	PF07531
Domain	-	AADACL4 NLGN4Y NLGN1 NLGN4X NLGN2 PNLIPRP3	1.01e-03	119	179	6	3.40.50.1820
Domain	AB_hydrolase	AADACL4 NLGN4Y NLGN1 NLGN4X NLGN2 PNLIPRP3	1.01e-03	119	179	6	IPR029058
Domain	VWFA	VWA8 ITGA1 ITGAD ITGAM ITGB2	1.15e-03	82	179	5	PS50234
Domain	FG_GAP	ITGA1 ITGAD ITGAM	1.17e-03	22	179	3	PS51470
Domain	VWA	VWA8 ITGA1 ITGAD ITGAM ITGB2	1.28e-03	84	179	5	SM00327
Domain	Gln_synth/guanido_kin_cat_dom	CKB CKM	1.34e-03	6	179	2	IPR014746
Domain	-	CKB CKM	1.34e-03	6	179	2	3.30.590.10
Domain	FG-GAP	ITGA1 ITGAD ITGAM	1.51e-03	24	179	3	PF01839
Domain	FG-GAP	ITGA1 ITGAD ITGAM	1.51e-03	24	179	3	IPR013517
Domain	Metal_Hydrolase	AMPD1 AMPD2 AMPD3	1.51e-03	24	179	3	IPR032466
Domain	PROTEIN_KINASE_ATP	CDC42BPG MAP4K3 CDKL3 SRPK2 ERN2 MAP3K6 RPS6KC1 EPHA2 TBK1 MAP3K9 FGFR2 MAP4K2	1.62e-03	459	179	12	PS00107
Domain	VWA	VWA8 ITGA1 ITGAD ITGAM	2.03e-03	56	179	4	PF00092
Domain	AT_hook	KMT2B KMT2C BOD1L1	2.14e-03	27	179	3	SM00384
Domain	AT_hook_DNA-bd_motif	KMT2B KMT2C BOD1L1	2.14e-03	27	179	3	IPR017956
Domain	Kinase-like_dom	CDC42BPG MAP4K3 CDKL3 SRPK2 ERN2 MAP3K6 RPS6KC1 EPHA2 TBK1 MAP3K9 FGFR2 MAP4K2 ALPK2	2.23e-03	542	179	13	IPR011009
Domain	Ser/Thr_kinase_AS	CDC42BPG MAP4K3 CDKL3 SRPK2 ERN2 MAP3K6 RPS6KC1 TBK1 MAP3K9 MAP4K2	2.39e-03	357	179	10	IPR008271
Domain	S_TKc	CDC42BPG MAP4K3 CDKL3 SRPK2 ERN2 MAP3K6 RPS6KC1 TBK1 MAP3K9 MAP4K2	2.49e-03	359	179	10	SM00220
Domain	PROTEIN_KINASE_ST	CDC42BPG MAP4K3 CDKL3 SRPK2 ERN2 MAP3K6 RPS6KC1 TBK1 MAP3K9 MAP4K2	2.64e-03	362	179	10	PS00108
Domain	VWF_A	VWA8 ITGA1 ITGAD ITGAM ITGB2	2.65e-03	99	179	5	IPR002035
Domain	Prot_kinase_dom	CDC42BPG MAP4K3 CDKL3 SRPK2 ERN2 MAP3K6 RPS6KC1 EPHA2 TBK1 MAP3K9 FGFR2 MAP4K2	2.72e-03	489	179	12	IPR000719
Domain	PROTEIN_KINASE_DOM	CDC42BPG MAP4K3 CDKL3 SRPK2 ERN2 MAP3K6 RPS6KC1 EPHA2 TBK1 MAP3K9 FGFR2 MAP4K2	2.91e-03	493	179	12	PS50011
Domain	Calx_beta	ADGRV1 FREM1	3.15e-03	9	179	2	IPR003644
Domain	Calx-beta	ADGRV1 FREM1	3.15e-03	9	179	2	PF03160
Pubmed	Multiple N-linked glycosylation sites critically modulate the synaptic abundance of neuroligin isoforms.	NLGN4Y NLGN1 NLGN4X NLGN2	4.21e-09	5	189	4	37865312
Pubmed	Synapse formation: if it looks like a duck and quacks like a duck ...	NLGN4Y NLGN1 NLGN4X NLGN2	4.21e-09	5	189	4	10996085
Pubmed	The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?	NLGN4Y NLGN1 NLGN4X NLGN2	1.26e-08	6	189	4	21838267
Pubmed	Autism-associated neuroligin-4 mutation selectively impairs glycinergic synaptic transmission in mouse brainstem synapses.	NLGN4Y NLGN1 NLGN4X NLGN2	1.26e-08	6	189	4	29724786
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATMIN CDC42BPG CDH26 NLGN4Y MBP SRPK2 WNT4 PPARA ADGRV1 SBNO2 MICU1 KIAA1671 RLF ZNF462 KMT2C TJP1 FARP1 TBK1 ANKAR ZFHX3 BOD1L1 NLGN2 CHD6 GREB1 PRDM15 TET3 CREB3L2	4.26e-08	1489	189	27	28611215
Pubmed	Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways.	NLGN4Y NLGN1 NLGN4X NLGN2	5.81e-08	8	189	4	30871858
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	AMPD2 EXOSC10 MYBBP1A WASHC2C MAP4K3 DDX42 DIDO1 TAB2 WASHC2A ZRANB3 TIAM2 SBNO2 RPS6KC1 KMT2C WWC2 RCOR1 P2RX4 FARP1 MAP3K9 BOD1L1 CEP295 ESPL1	1.28e-07	1084	189	22	11544199
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	CDC42BPG KMT2B PCDHGB3 ACLY DISC1 KTN1 PPIL6 ZNF226 RPS6KC1 KIAA1671 MST1 KMT2C TBK1 MAP3K9 BOD1L1 CEP295 CHD6 SPDYE16	1.30e-07	736	189	18	29676528
Pubmed	Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD gene exhibiting alternatively spliced 5'-exons.	AMPD1 AMPD2 AMPD3	1.58e-07	3	189	3	1400401
Pubmed	Platelet AMP deaminase. Purification and kinetic studies.	AMPD1 AMPD2 AMPD3	1.58e-07	3	189	3	7287721
Pubmed	Novel aspects of tetramer assembly and N-terminal domain structure and function are revealed by recombinant expression of human AMP deaminase isoforms.	AMPD1 AMPD2 AMPD3	1.58e-07	3	189	3	9857047
Pubmed	Molecular cloning of AMP deaminase isoform L. Sequence and bacterial expression of human AMPD2 cDNA.	AMPD1 AMPD2 AMPD3	1.58e-07	3	189	3	1429593
Pubmed	Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina.	NLGN4Y NLGN4X NLGN2	1.58e-07	3	189	3	21282647
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ATMIN FLNC KMT2B VWA8 MYO9B PPARA WASHC2A ABCA7 MYORG TIAM2 SBNO2 TBC1D24 KMT2C FAT1 INTS5 MGAT1 BTBD7 CTDP1 NLGN2 FGFR2 ESPL1 SOWAHB	1.77e-07	1105	189	22	35748872
Pubmed	SPARCL1 Promotes Excitatory But Not Inhibitory Synapse Formation and Function Independent of Neurexins and Neuroligins.	NLGN4Y NLGN1 NLGN4X NLGN2	2.71e-07	11	189	4	32973045
Pubmed	Behavioral phenotypes of genetic mouse models of autism.	NLGN4Y NLGN1 NLGN4X NLGN2	2.71e-07	11	189	4	26403076
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ATMIN WASHC2C NLGN1 WASHC2A ZNF365 IGDCC4 NEDD4 TENM4 BTBD7 BOD1L1 CHD6 SLC23A2 TET3	4.12e-07	407	189	13	12693553
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	TAB2 ADGRV1 ZNF462 KMT2C TENM4 ALMS1 PLCB1 CHD6 SLC23A2 UNC80	4.82e-07	225	189	10	12168954
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	KMT2B TRIM24 DENND4C GREB1L KIAA1671 RLF ZNF462 RCOR1 ALMS1 TBK1 ZFHX3 CHD6 WDR62	5.56e-07	418	189	13	34709266
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYO5B SLCO2B1 KTN1 SYTL2 BACE1 MYORG ZNF462 FAT2 ALMS1 CEP152 NLGN2 CGNL1 UNC80 KIF1C	5.98e-07	493	189	14	15368895
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A3 LRRC37A2 LRRC37A	6.29e-07	4	189	3	22419166
Pubmed	Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.	NLGN4Y NLGN4X NLGN2	6.29e-07	4	189	3	12669065
Pubmed	Homodimerization and isoform-specific heterodimerization of neuroligins.	NLGN4Y NLGN4X NLGN2	6.29e-07	4	189	3	22671294
Pubmed	Analysis of four neuroligin genes as candidates for autism.	NLGN4Y NLGN1 NLGN4X	6.29e-07	4	189	3	16077734
Pubmed	Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism.	NLGN4Y NLGN1 NLGN4X NLGN2	1.10e-06	15	189	4	18227507
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	AMPD2 DCP2 TAB2 MAP3K6 SYDE1 DENND4C NEDD4 KIAA1671 FSIP2 WWC2 ALMS1 TJP1 MAP3K9 BOD1L1 CEP152 CGNL1 WDR62 KIF1C	1.25e-06	861	189	18	36931259
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	WASHC2C TAB2 MSH2 ELP3 WASHC2A RCOR1 FARP1 TBK1 CEP152 KIF1C	1.30e-06	251	189	10	29778605
Pubmed	Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins.	NLGN1 NLGN4X NLGN2	1.57e-06	5	189	3	15620359
Pubmed	Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic changes.	ITGAD ITGAM ITGB2	1.57e-06	5	189	3	15210787
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	ADGRV1 RUNX1T1 FREM1 LGALS3BP IGDCC4 FAT2 CGNL1 ESPL1	1.97e-06	152	189	8	34299191
Pubmed	Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage.	AMPD1 AMPD2 AMPD3	3.12e-06	6	189	3	29079593
Pubmed	Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration.	ITGA1 ITGAM ITGB2	3.12e-06	6	189	3	10528208
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SMARCA5 VWA8 RBL1 PRSS56 OAS3 SRPK2 TRIM24 ABCA7 LGALS3BP KIAA1671 RCOR1 FAT1 ALMS1 BRDT TBK1 ZFHX3 CEP295 IQCM UNC80 WDR62	3.30e-06	1116	189	20	31753913
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	MYBBP1A SMARCA5 ACLY DDX42 DIDO1 TRIM24 ZNF462 KMT2C ZFHX3	3.60e-06	220	189	9	35785414
Pubmed	Interaction network of human early embryonic transcription factors.	SMARCA5 KMT2B TRIM24 KIAA1671 RLF ZNF462 KMT2C RCOR1 ALMS1 TBK1 ZFHX3	3.92e-06	351	189	11	38297188
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	FLNC CYP2A13 MYBBP1A SMARCA5 MYO5B PCDHGB3 TTC16 SLCO2B1 KTN1 DDX42 NMRAL1 CAT PPARA RPS6KC1 TJP1 CFAP74 BOD1L1 ISG20L2 CEP295 CHD6 DLEC1 ATP1A4 POLQ	4.07e-06	1442	189	23	35575683
Pubmed	Leukocyte-endothelial cell interactions - lessons from knockout mice.	ITGA1 ITGAM ITGB2	5.44e-06	7	189	3	10213866
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	SMARCA5 EED KMT2B DHX37 DIDO1 MSH2 ZNF226 TRIM24 RLF ZNF462 FSIP2 BOD1L1 CHD6 PRDM15	6.79e-06	608	189	14	36089195
Pubmed	DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors.	NLGN4Y NLGN1 NLGN4X NLGN2	1.15e-05	26	189	4	34848499
Pubmed	Microglia ablation alleviates myelin-associated catatonic signs in mice.	NLGN4Y MBP NLGN4X	1.30e-05	9	189	3	29252214
Pubmed	Binding of neuroligins to PSD-95.	NLGN1 NLGN4X NLGN2	1.30e-05	9	189	3	9278515
Pubmed	Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier.	ITGA1 ITGAD ITGAM ITGB2	1.34e-05	27	189	4	31541017
Pubmed	Evolutionary dynamism of the primate LRRC37 gene family.	LRRC37A3 LRRC37A2 LRRC37A	1.84e-05	10	189	3	23064749
Pubmed	FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands.	KMT2B SRPK2 ZFHX3	1.84e-05	10	189	3	9171351
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	WASHC2C MAP4K3 DHX37 TAB2 WASHC2A CKB KIAA1671 ALMS1 TJP1 FARP1 TBK1 CEP295 CEP152 CGNL1 WDR62 KIF1C	1.91e-05	853	189	16	28718761
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	DHX37 NLGN1 KMT2C BTBD7 NLGN2 CCDC180	2.20e-05	103	189	6	10819331
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	WASHC2C LRRC37A3 VWA8 LRRC37A PLCB1 GREB1	2.45e-05	105	189	6	9628581
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	FLNC EXOSC10 MYBBP1A SMARCA5 VWA8 DHX37 ARRDC5 DDX42 SMPD4 DIDO1 CBFA2T3 ZBED5 CKB ZNF462 INTS5 TJP1 FARP1 CHD6	2.80e-05	1082	189	18	38697112
Pubmed	Rrn3 phosphorylation is a regulatory checkpoint for ribosome biogenesis.	RRN3P2 RRN3	2.94e-05	2	189	2	12015311
Pubmed	Mac-1 (CD11b/CD18) as accessory molecule for Fc alpha R (CD89) binding of IgA.	ITGAM ITGB2	2.94e-05	2	189	2	12244179
Pubmed	FAT1 and MSH2 Are Predictive Prognostic Markers for Chinese Osteosarcoma Patients Following Chemotherapeutic Treatment.	MSH2 FAT1	2.94e-05	2	189	2	35279875
Pubmed	Shedding of large functionally active CD11/CD18 Integrin complexes from leukocyte membranes during synovial inflammation distinguishes three types of arthritis through differential epitope exposure.	ITGAM ITGB2	2.94e-05	2	189	2	20826754
Pubmed	Stimulation of neutrophil apoptosis by immobilized IgA.	ITGAM ITGB2	2.94e-05	2	189	2	12377937
Pubmed	Concentration-dependent activity of mometasone furoate and dexamethasone on blood eosinophils isolated from atopic children: modulation of Mac-1 expression and chemotaxis.	ITGAM ITGB2	2.94e-05	2	189	2	15454120
Pubmed	Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils.	ITGAM ITGB2	2.94e-05	2	189	2	16239529
Pubmed	MLL4 binds TET3.	KMT2B TET3	2.94e-05	2	189	2	38579707
Pubmed	Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages.	ITGAM ITGB2	2.94e-05	2	189	2	12496435
Pubmed	Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.	ITGAM ITGB2	2.94e-05	2	189	2	18981141
Pubmed	Chromosomal assignments of genes coding for human leukocyte common antigen, T-200, and lymphocyte function-associated antigen 1, LFA-1 beta subunit.	MBP ITGB2	2.94e-05	2	189	2	2955527
Pubmed	Induction of atrial fibrillation by neutrophils critically depends on CD11b/CD18 integrins.	ITGAM ITGB2	2.94e-05	2	189	2	24558493
Pubmed	Myocardial creatine kinase expression after left ventricular assist device support.	CKB CKM	2.94e-05	2	189	2	12039490
Pubmed	A molecular basis for integrin alphaMbeta 2 ligand binding promiscuity.	ITGAM ITGB2	2.94e-05	2	189	2	12377763
Pubmed	Creatine kinase transcript accumulation: effect of nerve during muscle development.	CKB CKM	2.94e-05	2	189	2	10417818
Pubmed	Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels.	DISC1 BACE1	2.94e-05	2	189	2	26062786
Pubmed	Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potential.	ITGAM ITGB2	2.94e-05	2	189	2	33305306
Pubmed	Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice.	ITGAM ITGB2	2.94e-05	2	189	2	9862668
Pubmed	Creatine kinase activity in normal and Duchenne muscular dystrophy fibroblasts.	CKB CKM	2.94e-05	2	189	2	7057800
Pubmed	A neuroprotective phase precedes striatal degeneration upon nucleolar stress.	RRN3P2 RRN3	2.94e-05	2	189	2	23764776
Pubmed	Ligand recognition specificity of leukocyte integrin αMβ2 (Mac-1, CD11b/CD18) and its functional consequences.	ITGAM ITGB2	2.94e-05	2	189	2	25613106
Pubmed	Stable adhesion and migration of human neutrophils requires phospholipase D-mediated activation of the integrin CD11b/CD18.	ITGAM ITGB2	2.94e-05	2	189	2	17346796
Pubmed	Inhibition of integrin αDβ2-mediated macrophage adhesion to end product of docosahexaenoic acid (DHA) oxidation prevents macrophage accumulation during inflammation.	ITGAD ITGAM	2.94e-05	2	189	2	31395659
Pubmed	The Systemic Lupus Erythematosus-Associated Single Nucleotide Polymorphism rs1143678 in Integrin αM Cytoplasmic Tail Generates a 14-3-3ζ Binding Site That Is Proinflammatory.	ITGAM ITGB2	2.94e-05	2	189	2	27974454
Pubmed	Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment.	ITGAM ITGB2	2.94e-05	2	189	2	20404138
Pubmed	Genetically increasing flux through β-oxidation in skeletal muscle increases mitochondrial reductive stress and glucose intolerance.	CAT PPARA	2.94e-05	2	189	2	33813880
Pubmed	LFA-1 and MAC-1 mediate pulmonary recruitment of neutrophils and tissue damage in abdominal sepsis.	ITGAM ITGB2	2.94e-05	2	189	2	18197144
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4Y NLGN4X	2.94e-05	2	189	2	23183221
Pubmed	Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.	NLGN4Y NLGN4X	2.94e-05	2	189	2	24855039
Pubmed	LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice.	ITGAM ITGB2	2.94e-05	2	189	2	9077544
Pubmed	Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.	NLGN4Y NLGN4X	2.94e-05	2	189	2	37001827
Pubmed	Frontline Science: The expression of integrin αD β2 (CD11d/CD18) on neutrophils orchestrates the defense mechanism against endotoxemia and sepsis.	ITGAD ITGB2	2.94e-05	2	189	2	33438263
Pubmed	The extracellular domain of CD11d regulates its cell surface expression.	ITGAD ITGB2	2.94e-05	2	189	2	19571252
Pubmed	Interaction of Bordetella adenylate cyclase toxin with complement receptor 3 involves multivalent glycan binding.	ITGAM ITGB2	2.94e-05	2	189	2	25554420
Pubmed	Non-motor symptoms associated with progressive loss of dopaminergic neurons in a mouse model of Parkinson's disease.	RRN3P2 RRN3	2.94e-05	2	189	2	38745938
Pubmed	Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp).	WASHC2C WASHC2A	2.94e-05	2	189	2	20827171
Pubmed	Modulation of CD11b/CD18 adhesive activity by its extracellular, membrane-proximal regions.	ITGAM ITGB2	2.94e-05	2	189	2	12847278
Pubmed	Ligand-specific binding forces of LFA-1 and Mac-1 in neutrophil adhesion and crawling.	ITGAM ITGB2	2.94e-05	2	189	2	29282280
Pubmed	Function of the growth-regulated transcription initiation factor TIF-IA in initiation complex formation at the murine ribosomal gene promoter.	RRN3P2 RRN3	2.94e-05	2	189	2	8413268
Pubmed	LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) distinctly regulate neutrophil extravasation through hotspots I and II.	ITGAM ITGB2	2.94e-05	2	189	2	30967528
Pubmed	Regulated unmasking of the cryptic binding site for integrin alpha M beta 2 in the gamma C-domain of fibrinogen.	ITGAM ITGB2	2.94e-05	2	189	2	12390020
Pubmed	The macrophage alphaMbeta2 integrin alphaM lectin domain mediates the phagocytosis of chilled platelets.	ITGAM ITGB2	2.94e-05	2	189	2	15741160
Pubmed	FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans.	WASHC2C WASHC2A	2.94e-05	2	189	2	36717248
Pubmed	Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations.	GREB1L GREB1	2.94e-05	2	189	2	29100090
Pubmed	AMP deaminase 3 plays a critical role in remote reperfusion lung injury.	AMPD2 AMPD3	2.94e-05	2	189	2	23542464
Pubmed	CR3 (CD11b/CD18) activation of nasal neutrophils: a measure of upper airway endotoxin exposure.	ITGAM ITGB2	2.94e-05	2	189	2	19863185
Pubmed	Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism.	RRN3P2 RRN3	2.94e-05	2	189	2	30918302
Pubmed	EM structure of the ectodomain of integrin CD11b/CD18 and localization of its ligand-binding site relative to the plasma membrane.	ITGAM ITGB2	2.94e-05	2	189	2	23469114
Pubmed	LFA-1 and Mac-1 define characteristically different intralumenal crawling and emigration patterns for monocytes and neutrophils in situ.	ITGAM ITGB2	2.94e-05	2	189	2	21037096
Pubmed	Structures and interaction analyses of integrin αMβ2 cytoplasmic tails.	ITGAM ITGB2	2.94e-05	2	189	2	22052909
Pubmed	Heat shock represses rRNA synthesis by inactivation of TIF-IA and lncRNA-dependent changes in nucleosome positioning.	RRN3P2 RRN3	2.94e-05	2	189	2	27257073
Pubmed	Neuroligin-2 deletion selectively decreases inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-positive interneurons.	NLGN1 NLGN2	2.94e-05	2	189	2	19889999
GeneFamily	Adenosine deaminase family	AMPD1 AMPD2 AMPD3	5.08e-06	6	116	3	1302
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA1 ITGAD ITGAM	1.96e-04	18	116	3	1160
GeneFamily	Mitogen-activated protein kinase kinase kinase kinases	MAP4K3 MAP4K2	4.03e-04	5	116	2	655
GeneFamily	WASH complex	WASHC2C WASHC2A	6.02e-04	6	116	2	1331
GeneFamily	Zinc fingers CXXC-type	KMT2B TET3	2.58e-03	12	116	2	136
GeneFamily	PHD finger proteins	KMT2B DIDO1 TRIM24 KMT2C	2.69e-03	90	116	4	88
Coexpression	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP	IL10RB AMPD3 WASHC2C MANBA VWA8 LRRC37A2 NCF4 ZNF226 WASHC2A ABCA7 KMT2C LRRC37A P2RX4 CARF	1.02e-06	392	188	14	M2131
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	SYN3 RBL1 MSH2 ZRANB3 CEP295 CEP152 POLQ ESPL1 WDR62	1.40e-07	193	188	9	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	DIDO1 MSH2 TRIM24 ZRANB3 GREB1L ELL2 PLCB1 CHD6 GREB1	1.40e-07	193	188	9	503a979328c68b096680b71359a26f02fafdff35
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CDH26 HTR1E ERN2 FAT1 FARP1 EPHA2 FGFR2 SEMA3E	1.10e-06	182	188	8	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMPD1 PPIL6 PPARA ZRANB3 FREM1 IGDCC4 GREB1L GREB1	1.19e-06	184	188	8	6b0c110d8930df99043c3b99cf4d873985126960
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMPD1 PPIL6 PPARA ZRANB3 FREM1 IGDCC4 GREB1L GREB1	1.19e-06	184	188	8	35928fc5f7bbf8c7b09181a2bd27e22dff42ec16
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	MYO5B ADGRV1 CKB WWC2 FARP1 FGFR2 CGNL1 SLC44A3	1.58e-06	191	188	8	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MANBA MYO9B MAP4K3 ETV6 KMT2C RCOR1 ELL2 MAML2	1.71e-06	193	188	8	779276e775cb2492e8dd36436295a536084a6415
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5B NLGN1 PPARA FAT1 FARP1 FGFR2 CGNL1 SLC44A3	1.78e-06	194	188	8	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CDH26 HTR1E ADGRV1 ERN2 FAT1 FARP1 EPHA2 SEMA3E	1.84e-06	195	188	8	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	DNHD1 AMPD3 PPIL6 ADGB CFAP74 DLEC1 EBF4	5.41e-06	160	188	7	6de505bfe1fbbe984718740a9cf43d0e02ff452e
ToppCell	367C-Myeloid-Monocyte-CD16+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ZNF597 LRRC37A2 ITGA1 WASHC2A MICU1 LRRC37A TET3	6.36e-06	164	188	7	1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518
ToppCell	367C-Myeloid-Monocyte-CD16+_Monocyte\|367C / Donor, Lineage, Cell class and subclass (all cells)	ZNF597 ITGAM WASHC2A MICU1 MGAT1 LRRC37A TET3	6.89e-06	166	188	7	430d604f5bef9fae20dc81492e6695616f6701a3
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PRSS56 AKAP3 CCDC168 FSIP2 GREB1	7.54e-06	64	188	5	bf923a66b17e717b8d3817b9d0e201b82a7e4a88
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PRSS56 AKAP3 CCDC168 FSIP2 GREB1	7.54e-06	64	188	5	a3e852600c53b11175eb579e92962fa711f5678b
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PRSS56 AKAP3 CCDC168 FSIP2 GREB1	7.54e-06	64	188	5	f8f43ad9354c786b418bac54614f96f50e8bea68
ToppCell	367C-Myeloid-Monocyte-CD16+_Monocyte\|Monocyte / Donor, Lineage, Cell class and subclass (all cells)	ZNF597 LRRC37A2 CDKL3 ITGA1 WASHC2A MICU1 LRRC37A	8.69e-06	172	188	7	fb8ab2576b5c38db63573a3bf46b8d9d634c4999
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMPD2 NLGN1 ITGA1 NEDD4 EBF2 P2RX4 TJP1	9.73e-06	175	188	7	a9f88054e2c28d604c65ed785f63021aadb7f4c8
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMPD2 NLGN1 ITGA1 NEDD4 EBF2 P2RX4 TJP1	9.73e-06	175	188	7	1b35acece23712ab7e3f92d9d68266efd38b3ef5
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO2B1 PPIL6 NLGN1 TIAM2 TBC1D24 FAT2 HECTD2	1.01e-05	176	188	7	27e5115fae5f0f63b333bc99fbf6a6d4c9182c46
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN1 GREB1L ZNF462 FAT1 FARP1 MAML2 ALPK2	1.25e-05	182	188	7	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYTL2 CBFA2T3 ERN2 P2RX4 ANKAR PLCB1 FGFR2	1.30e-05	183	188	7	5a936fb07074cec753bf19e3e3e52499605ea22c
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	MYO5B ADGRV1 WWC2 FARP1 CGNL1 SLC44A3 SEMA3E	1.30e-05	183	188	7	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYTL2 CBFA2T3 ERN2 P2RX4 ANKAR PLCB1 FGFR2	1.30e-05	183	188	7	07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NLGN4Y SYTL2 ITGA1 CBFA2T3 FAT1 PLCB1 ZFHX3	1.35e-05	184	188	7	689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC FAM185A FREM1 ADGB CFAP74 CCDC180 SLC44A3	1.35e-05	184	188	7	264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC FAM185A FREM1 ADGB CFAP74 CCDC180 SLC44A3	1.35e-05	184	188	7	d7eccbd21c480d907fdc8eff2bf5ae22ae452221
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC FAM185A FREM1 ADGB CFAP74 CCDC180 SLC44A3	1.35e-05	184	188	7	22010cfe0428ebfa40952cc1a1a12ad3d25b35c9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN1 GREB1L ZNF462 FAT1 FARP1 MAML2 ALPK2	1.44e-05	186	188	7	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	RBL1 MSH2 ZRANB3 FARP1 SPDYE2 PLCB1 GREB1	1.44e-05	186	188	7	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NPIPB11 ADGRV1 KMT2C TENM4 NPIPB13 ZFHX3 TET3	1.44e-05	186	188	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5B NLGN1 NEDD4 ZNF462 FAT1 FARP1 ALPK2	1.44e-05	186	188	7	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	RBL1 MSH2 ZRANB3 FARP1 SPDYE2 PLCB1 GREB1	1.44e-05	186	188	7	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	COVID-19-kidney-tDL\|kidney / Disease (COVID-19 only), tissue and cell type	MYO5B NLGN1 PPARA FAT1 FARP1 CGNL1 ALPK2	1.50e-05	187	188	7	d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	CDH26 ADGRV1 ERN2 FAT1 FGFR2 EBF4 SEMA3E	1.50e-05	187	188	7	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SMARCA5 ADGRV1 CKB EPHA2 FGFR2 SLC44A3 SEMA3E	1.66e-05	190	188	7	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	RBL1 MSH2 CEP295 CEP152 POLQ ESPL1 WDR62	1.66e-05	190	188	7	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	CDH26 ADGRV1 ERN2 FAT1 FARP1 FGFR2 SEMA3E	1.66e-05	190	188	7	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	COVID-19-Heart-Mito_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLNC PRSS56 F8 EBF2 CKM PLCB1 KIF1C	1.66e-05	190	188	7	ea74e0e38bcaba125b48c88331e9ba09228d3178
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN1 ZNF462 FAT1 FARP1 PLCB1 FGFR2 MAML2	1.71e-05	191	188	7	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CDH26 ADGRV1 ERN2 FAT1 FARP1 EPHA2 SEMA3E	1.71e-05	191	188	7	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO5B ADGRV1 CKB WWC2 FGFR2 CGNL1 SLC44A3	1.77e-05	192	188	7	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	CDH26 HTR1E ADGRV1 ERN2 FAT1 FARP1 SEMA3E	1.83e-05	193	188	7	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5B NLGN1 PPARA FAT1 FARP1 CGNL1 SLC44A3	1.83e-05	193	188	7	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS SLCO2B1 DISC1 ARRDC5 NCF4 ITGAM ITGB2	1.89e-05	194	188	7	0866ab6792cee274a71991d5c37a37f574ff446e
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B NLGN1 TRIM24 FARP1 FGFR2 CGNL1	1.91e-05	130	188	6	6434d9106ccb38786dad36fab80163dfc07b6eb7
ToppCell	Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MANBA MYO9B SLCO2B1 MGAT1 ELL2 P2RX4 TET3	1.96e-05	195	188	7	9d649ac7d2af313481069c95349efc0c68449e2b
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|lung / Disease (COVID-19 only), tissue and cell type	MANBA MYO9B SLCO2B1 ETV6 ITGAM MGAT1 TET3	1.96e-05	195	188	7	148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS SLCO2B1 DISC1 ARRDC5 CBFA2T3 ITGAM ITGB2	1.96e-05	195	188	7	2d485373bfd9bb4bb9236bf0b31d03e132c8018f
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDH26 FAM185A IP6K3 SYTL2 ERN2 TENM4 SPDYE16	2.02e-05	196	188	7	b07db4a53ab9be9aad6fae5e45f9547db829d096
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDH26 FAM185A IP6K3 SYTL2 ERN2 TENM4 SPDYE16	2.02e-05	196	188	7	c366f980cc04abfe1c0c14746c11810c812a42c0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLCO2B1 DISC1 ARRDC5 NCF4 CBFA2T3 ITGAM ITGB2	2.02e-05	196	188	7	4370473693d2dd4a8c451a4c477eb79baa33ae12
ToppCell	COVID-19-kidney-Macrophages\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AMPD3 MYO9B SLCO2B1 ETV6 ITGAM ITGB2 MGAT1	2.09e-05	197	188	7	3912301018d0863144dcfac8d1fa8adc081748d7
ToppCell	IPF-Myeloid-Macrophage\|IPF / Disease state, Lineage and Cell class	MANBA MYO9B SLCO2B1 ITGAM ITGB2 MGAT1 ELL2	2.09e-05	197	188	7	a2ffb33c7cad6be43cbb8ed9a91338923cc07db4
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	SMARCA5 SLCO2B1 MSH2 ITGAM ITGB2 ALMS1 ZFHX3	2.16e-05	198	188	7	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDH26 ADGRV1 ERN2 FAT1 FARP1 FGFR2 SEMA3E	2.16e-05	198	188	7	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RBL1 MSH2 CKM POLQ ESPL1 MAP4K2 WDR62	2.16e-05	198	188	7	d5e125f0c4f41b47d567568d0838adcca7655f6d
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	SMARCA5 SLCO2B1 MSH2 ITGAM ITGB2 ALMS1 ZFHX3	2.16e-05	198	188	7	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	SMARCA5 SLCO2B1 MSH2 ITGAM ITGB2 ALMS1 ZFHX3	2.16e-05	198	188	7	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9B SLCO2B1 DISC1 NCF4 CBFA2T3 ITGAM ITGB2	2.23e-05	199	188	7	04adf46975aa4194ea40c7480f8a517def5d929c
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EXOSC10 ITGA1 LGALS3BP FAT1 FGFR2 ALPK2 SLC44A3	2.23e-05	199	188	7	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO5B ADGRV1 ERN2 KIAA1671 FARP1 CGNL1 SLC44A3	2.30e-05	200	188	7	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	C8orf48 ALMS1 CEP295 CEP152 DLEC1 WDR62	5.50e-05	157	188	6	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP4K3 SLCO2B1 ITGAD LGALS3BP CKB P2RX4	6.11e-05	160	188	6	0544bc465af208da448858d6e174ff56f2e08a46
ToppCell	facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBP ETV6 NCF4 ITGAM ITGB2 TIAM2	6.55e-05	162	188	6	3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704
ToppCell	facs-Lung-nan-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBP ETV6 NCF4 ITGAM ITGB2 TIAM2	6.55e-05	162	188	6	8134f73eb76693f4f1845f643042fdc1e81c274c
ToppCell	facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MBP ETV6 NCF4 ITGAM ITGB2 TIAM2	6.77e-05	163	188	6	bbbc3f0ce2616d07136f69ce682ba1d3790711d9
ToppCell	facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MBP ETV6 NCF4 ITGAM ITGB2 TIAM2	7.01e-05	164	188	6	11dfd84f5fb90de330858e1e852848832734e004
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	DNHD1 PPIL6 ADGB CFAP74 DLEC1 EBF4	7.25e-05	165	188	6	731147b4337fd0de4383dc8170b4f9ccd98caec6
ToppCell	droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBP ETV6 TAB2 CBFA2T3 ITGAM TIAM2	7.25e-05	165	188	6	0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09
ToppCell	droplet-Lung-nan-18m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBP ETV6 TAB2 CBFA2T3 ITGAM TIAM2	7.25e-05	165	188	6	e32697321cef424c2ad4e11ee9da3e510d5ce505
ToppCell	facs-Lung-nan-3m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBP OAS3 NCF4 ITGAM ITGB2 TIAM2	7.25e-05	165	188	6	720649f330382ea2a68c64a5344160a048afb8f1
ToppCell	droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MBP ETV6 TAB2 CBFA2T3 ITGAM TIAM2	8.00e-05	168	188	6	00cff4698db14e03ca1d1b409e5ed1ad23b12615
ToppCell	droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBP PPM1M CBFA2T3 ITGB2 MAP3K9 UNC80	8.00e-05	168	188	6	22c89d4eb44573f6301069ec7ca7cbd0dd958403
ToppCell	droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBP PPM1M CBFA2T3 ITGB2 MAP3K9 UNC80	8.00e-05	168	188	6	ce5e92a1df3acfa5cd8d5a134e4af231dc592a13
ToppCell	droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MBP ETV6 TAB2 CBFA2T3 ITGAM TIAM2	8.27e-05	169	188	6	90c00ab30e582b0e2a2be751e1fae9024cfb9ea6
ToppCell	TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4\|TCGA-Adrenal / Sample_Type by Project: Shred V9	MYO9B SYTL2 TRIM24 IGDCC4 CLCN2 FARP1	9.71e-05	174	188	6	15e2b9f46404ff9575e149024b24cb17b50b02b5
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	MYO5B WWC2 TJP1 FARP1 CGNL1 SEMA3E	9.71e-05	174	188	6	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN1 PPARA MST1 FARP1 GREB1 ALPK2	1.07e-04	177	188	6	2f81b26be89cc2fd8eafadaf7eae3c6ad6521462
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC16 WNT4 ADGB CFAP74 CCDC180 SLC44A3	1.10e-04	178	188	6	b1db59344c074c7c80169fc2c5cd5fc89f3fe463
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC16 WNT4 ADGB CFAP74 CCDC180 SLC44A3	1.10e-04	178	188	6	579cdc14f28b459e200ae2102e0bd4df8a2c0dcb
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PLCD4 ITGA1 IGDCC4 EBF2 FAT1 EBF4	1.13e-04	179	188	6	98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO5B ADGRV1 WWC2 FARP1 FGFR2 CGNL1	1.13e-04	179	188	6	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO5B WWC2 TJP1 FARP1 CGNL1 SEMA3E	1.13e-04	179	188	6	4f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	MYO5B ADGRV1 WWC2 FARP1 CGNL1 SLC44A3	1.13e-04	179	188	6	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B NLGN1 ADGRV1 TRIM24 TENM4 FGFR2	1.13e-04	179	188	6	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPIL6 C8orf48 ADGB CEP152 CCDC180 WDR62	1.17e-04	180	188	6	0c146e80d55d18b6988dd21b1da635801bd3140c
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPIL6 C8orf48 ADGB CEP152 CCDC180 WDR62	1.17e-04	180	188	6	e9af22beae2f3c7fe213b4e19df84abfd2453433
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPIL6 C8orf48 ADGB CEP152 CCDC180 WDR62	1.17e-04	180	188	6	11455ba704ac73f69b474845136cfecec6a88349
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYO5B NLGN1 FAT1 FARP1 CGNL1 ALPK2	1.17e-04	180	188	6	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	COVID-19-kidney-tDL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYO5B NLGN1 PPARA FAT1 FARP1 CGNL1	1.17e-04	180	188	6	864c895b5eaedefae86f5829fa344f7b686fb59f
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM185A MAP4K3 F8 ELL2 CLCN2 DLEU7	1.21e-04	181	188	6	e2d03115a87f45a7ddd3ade6b9ac3843639bd41a
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B NLGN1 WWC2 FARP1 CGNL1 SEMA3E	1.21e-04	181	188	6	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM185A MAP4K3 F8 ELL2 CLCN2 DLEU7	1.21e-04	181	188	6	d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	AMPD3 ARRDC5 NCF4 ITGAM ABCA7 DLEC1	1.24e-04	182	188	6	52eac2f892ea7f26731e0b21c578fd2665a1657a
ToppCell	COVID-19-Heart-EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SYN3 ITGA1 CBFA2T3 F8 EBF2 PLCB1	1.24e-04	182	188	6	e67f3234165199085c793915ebb1f9bbd845e933
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYO5B PPIL6 ADGB CFAP74 DLEC1 CCDC180	1.24e-04	182	188	6	000eca5baa6eb2335a1e6d76a13fff5382b0e150
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NLGN4Y SYTL2 ITGA1 CBFA2T3 PLCB1 ZFHX3	1.28e-04	183	188	6	8a799807fbf24456a9811e0c64068187940a2f71
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 FREM1 FAT1 TENM4 ATP1A4 UNC80	1.32e-04	184	188	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR1E CAT NLGN1 ADGRV1 FGFR2 SLC44A3	1.32e-04	184	188	6	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 FREM1 FAT1 TENM4 ATP1A4 UNC80	1.32e-04	184	188	6	2b19a8c5f823e00812908b23e66bb4e563278aff
Drug	Abbott-40557	AMPD1 AMPD2 AMPD3	5.28e-07	3	185	3	CID000161884
Drug	C-d4G	AMPD1 AMPD2 AMPD3	5.28e-07	3	185	3	CID000461321
Drug	AC1LAJJO	AMPD1 AMPD2 AMPD3	5.28e-07	3	185	3	CID000469587
Drug	AC1LANXR	AMPD1 AMPD2 AMPD3	5.28e-07	3	185	3	CID000471863
Drug	pyrachlostrobin	IL10RB CDC42BPG FLNC MANBA MYO5B SYTL2 PLCD4 ITGA1 ADGRV1 ITGAM ITGB2 SYDE1 DENND4C LGALS3BP IGDCC4 FAT1 EPHA2 FGFR2 MAML2 CGNL1 CREB3L2 KIF1C	7.90e-07	811	185	22	ctd:C513428
Drug	Hlamp	AMPD1 AMPD2 AMPD3 ITGB2	1.33e-06	11	185	4	CID000195011
Drug	2',3'-Dideoxyadenylosuccinate	AMPD1 AMPD2 AMPD3	2.10e-06	4	185	3	CID000126574
Drug	2'-deoxycoformycin-5'-phosphate	AMPD1 AMPD2 AMPD3	2.10e-06	4	185	3	CID000188258
Drug	inosine 5'-phosphosulfate	AMPD1 AMPD2 AMPD3	2.10e-06	4	185	3	CID003082299
Drug	2,3-dibromopropene	AMPD1 AMPD2 AMPD3	5.22e-06	5	185	3	CID000010552
Drug	2,6-diaminopurine analog	AMPD1 AMPD2 AMPD3	5.22e-06	5	185	3	CID000469176
Drug	CBVMP	AMPD1 AMPD2 AMPD3	5.22e-06	5	185	3	CID000469585
Drug	Suramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A	CDKL3 MAP3K6 ABCA7 SBNO2 CLCN2 EPHA2 CARF SLC23A2 MAP4K2 DNPEP	5.57e-06	199	185	10	7496_UP
Drug	NSC623156	AMPD1 AMPD2 AMPD3	1.04e-05	6	185	3	CID000360780
Drug	allantoin	AMPD1 AMPD2 AMPD3 CAT ZNF365	1.18e-05	37	185	5	CID000000204
Drug	coaristeromycin	AMPD1 AMPD2 AMPD3	1.80e-05	7	185	3	CID000097182
Drug	adenosine-5'-carboxylic acid	AMPD1 AMPD2 AMPD3	1.80e-05	7	185	3	CID000097627
Drug	Iobenguane sulfate; Down 200; 10.8uM; MCF7; HT_HG-U133A	DISC1 ETV6 ERN2 MAP3K6 CLCN2 EPHA2 CTDP1 FGFR2 DNPEP	3.80e-05	199	185	9	2878_DN
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	HTR1E MANBA DISC1 ETV6 PPARA ERN2 ABCA7 CTDP1 FGFR2	3.95e-05	200	185	9	6970_UP
Drug	N-hydroxyglycine	AMPD1 AMPD2 AMPD3	4.28e-05	9	185	3	CID000019070
Drug	6-methoxy-5H-purine	AMPD1 AMPD2 AMPD3	4.28e-05	9	185	3	CID000409801
Disease	pontocerebellar hypoplasia (implicated_via_orthology)	AMPD1 AMPD2 AMPD3	2.29e-06	5	182	3	DOID:0060264 (implicated_via_orthology)
Disease	Adenosine monophosphate deaminase deficiency	AMPD1 AMPD3	3.78e-05	2	182	2	C2931781
Disease	Muscle AMP deaminase deficiency	AMPD1 AMPD3	3.78e-05	2	182	2	C0268123
Disease	Squamous cell carcinoma of lung	MAP4K3 TRIM24 EPHA2 FGFR2	4.40e-05	32	182	4	C0149782
Disease	schizophrenia (implicated_via_orthology)	DISC1 BACE1 PPARA PLCB1 NLGN2	6.43e-05	68	182	5	DOID:5419 (implicated_via_orthology)
Disease	Colonic diverticula	OAS3 WNT4	1.13e-04	3	182	2	HP_0002253
Disease	Schizophrenia	SYN3 MYO5B MYO9B DISC1 MBP BACE1 NLGN1 PPARA ITGAM SBNO2 CKB TENM4 PLCB1 NLGN2 FGFR2 CGNL1	1.25e-04	883	182	16	C0036341
Disease	body surface area	SYN3 MYO9B ETV6 DIDO1 WNT4 PPARA TIAM2 ZNF462 WWC2 DLEU7 ZFHX3 DLEC1 SOWAHB	1.92e-04	643	182	13	EFO_0022196
Disease	Craniosynostosis	FREM1 ZNF462 FGFR2	2.44e-04	20	182	3	C0010278
Disease	Squamous cell carcinoma of esophagus	DIDO1 KMT2C FAT1 FAT2 DLEC1	3.13e-04	95	182	5	C0279626
Disease	autism spectrum disorder (implicated_via_orthology)	SYN3 NLGN4Y NLGN1 NLGN4X NLGN2 CHD6	3.73e-04	152	182	6	DOID:0060041 (implicated_via_orthology)
Disease	Congenital absence of kidneys syndrome	FREM1 GREB1L	3.74e-04	5	182	2	C1609433
Disease	CHARGE syndrome (implicated_via_orthology)	CHD6 SEMA3E	7.79e-04	7	182	2	DOID:0050834 (implicated_via_orthology)
Disease	anxiety, smoking behaviour measurement	FGF5 UNC80	7.79e-04	7	182	2	EFO_0005230, EFO_0005671
Disease	reticulocyte count	AMPD3 VWA8 MYO9B ACLY PPIL6 ITGA1 ITGAD SBNO2 GREB1L RCOR1 FAT1 TBK1 PLCB1 DLEU7 SLC23A2 KIF1C	7.94e-04	1045	182	16	EFO_0007986
Disease	Myopathy	AMPD1 PPARA MICU1	8.29e-04	30	182	3	C0026848
Disease	diastolic blood pressure, systolic blood pressure	CBFA2T3 SYDE1 KIAA1671 TENM4 ALMS1 FARP1 ZFHX3 CHD6 DLEC1 MAP4K2 WDR62 CREB3L2	9.78e-04	670	182	12	EFO_0006335, EFO_0006336
Disease	oxalate measurement	SRPK2 DLEC1 SLC23A2	1.00e-03	32	182	3	EFO_0010517
Disease	Autistic behavior	ZNF462 TET3	1.03e-03	8	182	2	C0856975
Disease	Unilateral agenesis of kidney	FREM1 GREB1L	1.03e-03	8	182	2	C0266294
Disease	Developmental Coordination Disorder	DISC1 FGFR2	1.03e-03	8	182	2	C0011757
Disease	Motor Skills Disorders	DISC1 FGFR2	1.03e-03	8	182	2	C0026613
Disease	generalized anxiety disorder (implicated_via_orthology)	HTR1E ZNF462	1.03e-03	8	182	2	DOID:14320 (implicated_via_orthology)
Disease	multiple sclerosis	IL10RB THEMIS MANBA MYO5B VWA8 ETV6 NCF4 CBFA2T3 RCOR1 ZFHX3 ALPK2	1.22e-03	594	182	11	MONDO_0005301
Disease	comparative body size at age 10, self-reported	AMPD1 LRRC37A2 ETV6 PLCD4 SPDYE18 ELP3 EBF2 ZNF462 BTBD7	1.25e-03	420	182	9	EFO_0009819
Disease	estrogen-receptor positive breast cancer	AMPD2 FGFR2	1.32e-03	9	182	2	EFO_1000649
Disease	Experimental Autoimmune Encephalomyelitis	MBP PPARA	1.32e-03	9	182	2	C0014072
Disease	gout	CDC42BPG RUNX1T1 FAT1 FGF5 FGFR2 ATP1A4	1.41e-03	196	182	6	EFO_0004274
Disease	Carcinoma, Transitional Cell	KMT2C CHD6 ESPL1	2.07e-03	41	182	3	C0007138
Disease	volumetric bone mineral density	MAP4K3 WNT4 ADGRV1	2.22e-03	42	182	3	EFO_0007620
Disease	cardiovascular disease	MYO9B BACE1 FREM1 CKB EBF2 EPHA2 PLCB1 DLEU7 FGF5	2.22e-03	457	182	9	EFO_0000319
Disease	spleen volume	MYO9B TJP1 KIF1C	2.38e-03	43	182	3	EFO_0600047
Disease	nervous system disease (implicated_via_orthology)	ATP1A4 KIF1C	2.40e-03	12	182	2	DOID:863 (implicated_via_orthology)
Disease	Crohn's disease of large bowel	NCF4 PPARA MST1	2.54e-03	44	182	3	C0156147
Disease	IIeocolitis	NCF4 PPARA MST1	2.54e-03	44	182	3	C0949272
Disease	Crohn's disease of the ileum	NCF4 PPARA MST1	2.54e-03	44	182	3	C0267380
Disease	Regional enteritis	NCF4 PPARA MST1	2.54e-03	44	182	3	C0678202
Disease	Gastric Adenocarcinoma	BRDT EPHA2 MAP3K9	2.71e-03	45	182	3	C0278701
Disease	esophagus squamous cell carcinoma (is_implicated_in)	MSH2 KMT2C FAT1	2.71e-03	45	182	3	DOID:3748 (is_implicated_in)
Disease	Malignant neoplasm of breast	SLCO2B1 KTN1 LRRC37A2 CAT ELP3 MAP3K6 ZNF365 NEDD4 MST1 LRRC37A FARP1 PLCB1 BOD1L1 DLEC1 FGFR2	2.80e-03	1074	182	15	C0006142
Disease	Bipolar Disorder	SYN3 DISC1 SRPK2 NLGN1 ITGAM NEDD4 TENM4 PLCB1 FGFR2	2.96e-03	477	182	9	C0005586
Disease	transient cerebral ischemia (biomarker_via_orthology)	MBP BACE1 ITGAM FGFR2 SEMA3E	2.96e-03	157	182	5	DOID:224 (biomarker_via_orthology)
Disease	upper face morphology measurement	HTR1E ADGRV1 DLEC1 CREB3L2	3.11e-03	97	182	4	EFO_0010949
Disease	triacylglycerol 48:4 measurement	MBP TENM4	3.28e-03	14	182	2	EFO_0010407
Disease	lung adenocarcinoma (is_implicated_in)	MSH2 KMT2C ZFHX3	3.45e-03	49	182	3	DOID:3910 (is_implicated_in)
Disease	Crohn Disease	NCF4 PPARA MST1	3.66e-03	50	182	3	C0010346
Disease	Bell's palsy	DISC1 TENM4 FARP1 CEP295	3.72e-03	102	182	4	EFO_0007167
Disease	Autosomal recessive primary microcephaly	CEP152 WDR62	3.77e-03	15	182	2	cv:C3711387
Disease	ovarian carcinoma	AMPD1 WNT4 PPARA ADGRV1 ADGB ZFHX3 DLEC1	3.91e-03	321	182	7	EFO_0001075
Disease	Synostotic Posterior Plagiocephaly	FREM1 FGFR2	4.29e-03	16	182	2	C1833340
Disease	Craniosynostosis, Type 1	FREM1 FGFR2	4.29e-03	16	182	2	C4551902
Disease	Acrocephaly	FREM1 FGFR2	4.29e-03	16	182	2	C0030044
Disease	Trigonocephaly	FREM1 FGFR2	4.29e-03	16	182	2	C0265535
Disease	Scaphycephaly	FREM1 FGFR2	4.29e-03	16	182	2	C0265534
Disease	Huntington's disease (biomarker_via_orthology)	MBP CAT	4.29e-03	16	182	2	DOID:12858 (biomarker_via_orthology)
Disease	phosphorus measurement	IP6K3 ETV6	4.29e-03	16	182	2	EFO_0004861
Disease	Synostotic Anterior Plagiocephaly	FREM1 FGFR2	4.29e-03	16	182	2	C2931150
Disease	Metopic synostosis	FREM1 FGFR2	4.29e-03	16	182	2	C1860819
Disease	Dupuytren Contracture	TAB2 NEDD4 EBF2 FGFR2	4.56e-03	108	182	4	EFO_0004229
Disease	clonal hematopoiesis mutation measurement	MSH2 PLCB1 FGFR2	4.79e-03	55	182	3	EFO_0020949
Disease	Brachycephaly	FREM1 FGFR2	4.84e-03	17	182	2	C0221356
Disease	caudal anterior cingulate cortex volume measurement	FAT2 DLEU7	4.84e-03	17	182	2	EFO_0010289
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	IL10RB TJP1	4.84e-03	17	182	2	DOID:8677 (biomarker_via_orthology)
Disease	hepatocellular carcinoma (is_implicated_in)	KMT2B CAT PPARA ZFHX3 FGFR2	5.41e-03	181	182	5	DOID:684 (is_implicated_in)
Disease	Malignant neoplasm of endometrium	MSH2 FGFR2	5.42e-03	18	182	2	C0007103
Disease	Carcinoma in situ of endometrium	MSH2 FGFR2	5.42e-03	18	182	2	C0346191
Disease	adverse effect, response to xenobiotic stimulus	NLGN1 CTDP1 PLCB1	5.82e-03	59	182	3	EFO_0009658, GO_0009410
Disease	reticulocyte measurement	AMPD3 VWA8 MYO9B PPIL6 ITGA1 CBFA2T3 ITGAD SBNO2 RCOR1 FAT1 TBK1 PLCB1 DLEU7 SLC23A2	5.89e-03	1053	182	14	EFO_0010700
Disease	laryngeal squamous cell carcinoma (is_marker_for)	CAT MSH2	6.04e-03	19	182	2	DOID:2876 (is_marker_for)
Disease	emphysema pattern measurement	VWA8 SOWAHB	6.04e-03	19	182	2	EFO_0005850
Disease	lymphocyte measurement	MANBA ITGA1 ABCA7 DNPEP	6.04e-03	117	182	4	EFO_0803546

Protein segments in the cluster

Peptide	Gene	Start	Entry
DHTKAQRENSPAAFP	CTDP1	731	Q9Y5B0
PFFDSLVKQTHVPNL	BACE1	196	P56817
VLKPVSQHPRDFFSR	ARID5A	351	Q03989
KHLNSLPRNVSPEFV	CEP152	1451	O94986
HIFEGITKQLPDFNP	ERVK13-1	436	Q9NX77
QSHKNLIPFRPSIQF	ELL2	46	O00472
RDPILFPSFIHSQKR	CAT	156	P04040
LLKFVNRSPSPFHAV	DNPEP	31	Q9ULA0
QDVFETHFSKIPIEP	BRDT	366	Q58F21
EKQAPRFEPQISTVH	ADGB	1336	Q8N7X0
PRASHEKVSQFPSQV	ALPK2	1041	Q86TB3
SPHLQNIFSKSPIFA	CDKL3	221	Q8IVW4
EFHFPELPVTIQSKD	CDKL3	521	Q8IVW4
FEKFHASIRIPPFDN	HTR1E	256	P28566
PEPDETFIFHLTLQK	ADGRV1	106	Q8WXG9
FHREKSNIFSPQELP	ALMS1	2096	Q8TCU4
LQLKSHSPFQNFIPD	ALMS1	2646	Q8TCU4
VALSRAHFEKQPPSN	EBF2	46	Q9HAK2
TDIPATLQHPAKLRF	AADACL4	31	Q5VUY2
LTTEVFRKQLDPFPH	ANGPTL5	126	Q86XS5
INPQADPELSVFLKH	AMPD1	491	P23109
TKFRHSQQLFPDGSP	DCP2	271	Q8IU60
HPQEKPSDLVFSQEL	DNHD1	2811	Q96M86
LSTDDPLQFHFTKEP	AMPD2	761	Q01433
VIFKFRQPEAHEKPS	CCDC180	646	Q9P1Z9
EKISLHFQLPSRQPA	DISC1	386	Q9NRI5
LQHPKRVSQFLDDPS	ABCA7	2126	Q8IZY2
IFLPLFKATINPQDH	AMPD3	496	Q01432
QSHVPFAPAELKVQA	IGDCC4	626	Q8TDY8
HNIEKSLADLPNFTP	RCOR1	176	Q9UKL0
EPLSFTLEFHFKPNE	NAP1L2	281	Q9ULW6
THVPQPAFLKAAENF	P2RX4	171	Q99571
SEHLQEPPQRISFKE	IQCM	96	A0A1B0GVH7
FVRSKLISPPTNFNH	CDC42BPG	1431	Q6DT37
RPTAEKLLQHPFTTQ	MAP4K2	261	Q12851
LRNHPSPNIKVEVAF	ANKAR	1091	Q7Z5J8
SNFERHQPDTKLPTE	C8orf48	96	Q96LL4
PLILNPRHSVDFKQS	ETV6	276	P41212
NENLHPPVFSSFVEK	FAT1	1026	Q14517
HAVPSQRPTFKQLVE	FGFR2	741	P21802
RPTAEKLLQHPFVTQ	MAP4K3	261	Q8IVH8
QSIERHTFEPLPFLK	LRRC37A3	926	O60309
FFHNTPKEVRLDPSD	PNLIPRP3	196	Q17RR3
HFTKPSPRADVFQRQ	KMT2C	2006	Q8NEZ4
FLKHLENPPTSQRIE	KIAA1671	716	Q9BY89
QSIERHTFEPLPFLK	LRRC37A2	926	A6NM11
QSIERHTFEPLPFLK	LRRC37A	926	A6NMS7
FQTPQHPSFLFQDKR	LGALS3BP	461	Q08380
APNGRPFFIDHNTKT	NEDD4	851	P46934
FENLLSHFLPQKAPD	NMRAL1	156	Q9HBL8
QSFSRKLPFPDETHE	GPAA1	106	O43292
EPHSIRPFQLAVAQK	GREB1	656	Q4ZG55
DLSSIAVPPDHRKFQ	MGAT1	166	P26572
QLIDDHFLFDKPVSP	CKB	186	P12277
PLQQERSFPIHLKDS	DLEU7	141	Q6UYE1
HSKLQEATNFPLRPF	RUNX1T1	166	Q06455
QIHKNLFRHSELFPP	RPS6KC1	66	Q96S38
PSTQLRAHELKFFPN	RPS6KC1	561	Q96S38
HKETPFQNPLFVEAE	ARRDC5	161	A6NEK1
KQQETPLAPADFAHI	ERN2	461	Q76MJ5
LQHPLRSPTKFINSF	KIAA2026	1956	Q5HYC2
IHPQASVEVNAPLKF	FAM185A	136	Q8N0U4
RSSPAHLVFPNIKNV	HECTD2	76	Q5U5R9
LFKPDEVPERHNLSF	CARF	451	Q8N187
FQIHPDLIANLPFKS	FSIP2	4741	Q5CZC0
IPAENSPTRQQFHSK	DDX42	91	Q86XP3
LHRPLFAFPDAVKQI	MAP3K6	1076	O95382
DFVRSITPNEKQPEH	MICU1	151	Q9BPX6
NDNPPIFSHKLFNVR	FAT2	1236	Q9NYQ8
LFANQEIPASPFHIK	FLNC	846	Q14315
DQPHSFFPESQLRAK	FREM1	201	Q5H8C1
EFQSALPKINSHPTR	ISG20L2	121	Q9H9L3
QFHALQSKLEERFGP	NCF4	61	Q15080
KLRFPFKSNPQHRES	KIF1C	976	O43896
QQASSFPPHEELLKV	KTN1	986	Q86UP2
NRPFISQKIHFPDFS	EED	286	O75530
VEFTDHLFNIAKPRP	F8	71	P00451
LLRAPQFTPSEAHLK	KMT2B	646	Q9UMN6
VPQDTKFIHTKPNRF	NLGN1	596	Q8N2Q7
YLSPDPHFSLIQKEN	PCDHGB3	171	Q9Y5G1
RPHIFEDPFSINSGK	ITGA1	1031	P56199
FHSKLQEATNFPLRP	CBFA2T3	216	O75081
PTFEDENFSVPHNKR	PPIL6	226	Q8IXY8
FPKAIHNFRSPVLAI	GREB1L	1801	Q9C091
KALLRSEPHLNTPAF	IP6K3	141	Q96PC2
ETKHPFSFPLENQAR	MYBBP1A	496	Q9BQG0
LHAFANSLKPEQASP	SMPD4	376	Q9NXE4
ERKPPQHSDFLTQIS	ITGAD	996	Q13349
KTPAEHLQFRFHPQR	NPIPB11	581	E5RHQ5
PRQGNTKPLFHFNSD	MAML2	551	Q8IZL2
ISTHFLPRFKQSEQP	FGF5	211	P12034
FVDKTVLPFVNTHPD	ITGB2	171	P05107
PQDTKFIHTKPNRFE	NLGN4Y	541	Q8NFZ3
SQVVDPKINHTFRPQ	BOD1L1	136	Q8NFC6
ELNHFTPADAVLQKP	EXOSC10	261	Q01780
GPERPFSQFSLVKQH	ATMIN	141	O43313
HFPQPEKESFQERLA	ESPL1	1686	Q14674
SNPRDFNPQHFLDKK	CYP2A13	406	Q16696
DFRKTHSPDAPDFQL	CHD6	761	Q8TD26
SVKPSHLLNFQRHPE	CGNL1	136	Q0VF96
EKQPPSNLRKSNFFH	EBF4	56	Q9BQW3
VVKFFPPDHTQLQEE	FARP1	116	Q9Y4F1
DPNQAVLKFTTEIHP	EPHA2	596	P29317
FPVQEKNHTVVSPRA	POLQ	1576	O75417
APFSEKNEQTPSRFH	DIDO1	1996	Q9BTC0
HKPVSSLAEPDLINF	DENND4C	1571	Q5VZ89
AAAELLQNPHKFFPD	BTBD7	701	Q9P203
VVPVSSRDPTKFQHQ	ELP3	481	Q9H9T3
FSPRNSLPQHLKEFL	IL10RB	256	Q08334
LHFKLPQSTDPLRTF	MANBA	601	O00462
DENPVVHFFKNIVTP	MBP	216	P02686
HAPQFPEKEFNITVQ	CDH26	161	Q8IXH8
FNRSKNDPPDHPILS	SLC44A3	411	Q8N4M1
PESVFFSKIHPLQIE	CCDC168	2721	Q8NDH2
QSPHENSSLIRKFPQ	CCDC168	6681	Q8NDH2
KPQFTFTSEPHAQLE	MST1	401	P26927
IIPTFQDKSLSFPQH	CEP295	1141	Q9C0D2
ESRNHFLKNPRFFPP	DLEC1	321	Q9Y238
QFPVTVHFNKRTPLE	DHX37	436	Q8IY37
HEFLVKPSFDPNLSE	MSH2	466	P43246
VPQDTKFIHTKPNRF	NLGN2	551	Q8NFZ4
PQDTKFIHTKPNRFE	NLGN4X	541	Q8N0W4
QGRPFNSKPELLHFQ	CFAP74	511	Q9C0B2
ERFKRDPNQSLTPTH	MAP3K9	886	P80192
QFLNFSPKEAPVDHL	CREB3L2	186	Q70SY1
PKFDPRTFHNDLALV	PRSS56	181	P0CW18
SADDNIKTPAFHPQR	NPIPB13	571	A6NJU9
PKSRHPEEQQKVFFL	OR2A1;	261	Q8NGT9
LDRFIQDHLKPSPQF	OAS3	416	Q9Y6K5
HLQSNHPDDIFLFPK	PPARA	411	Q07869
SNFQPSLRHIDPETK	MUC17	4466	Q685J3
ALENDFFNSPPRKTV	RRN3	36	Q9NYV6
PFNPHLNLKDFDALI	SYDE1	706	Q6ZW31
HVRFSAVKDELPQSP	SYTL2	331	Q9HCH5
EKFPLVEQTFFPNHK	SYN3	221	O14994
HSEPLFRKDFQQINP	TMC3	851	Q7Z5M5
DFLRDIQSSFHPEKP	PLCD4	606	Q9BRC7
KEIDLFQARGPHFNP	TAB2	611	Q9NYJ8
QLIDDHFLFDKPVSP	CKM	186	P06732
QQHFEKKRSFAPSTP	RBL1	356	P28749
PHEIPLNVNTHKFSD	PRDM15	226	P57071
DNQPLHIFDKLHTSP	PPWD1	211	Q96BP3
APSTHDKLFQLSRPF	SBNO2	141	Q9Y2G9
QLEKGQTPPESHFQR	SPATA31E1	1251	Q6ZUB1
REHGPLPQKFIFQSE	INTS5	951	Q6P9B9
NTIASKPPRDHVFQV	ITGAM	301	P11215
KPPRDHVFQVNNFEA	ITGAM	306	P11215
KSFLRDPDASPSQHQ	SOWAHB	31	A6NEL2
FLKNFLIEPFVPHSQ	ACLY	101	P53396
HAAFEAPNTQRKPAS	AKAP3	476	O75969
HPEIVFARTSPQQKL	ATP1A4	691	Q13733
DPAPFQLVERTSLHK	CLCN2	791	P51788
PFLAARHFNLPSKTE	TBC1D24	481	Q9ULP9
SEIRSNFPKRHFLIP	THEMIS	321	Q8N1K5
TSQRPVFCPFHKKEQ	TRIM24	216	O15164
KVHPPTESILFNDVF	WWC2	756	Q6AWC2
QALKEDFPLSHVISP	UNC80	2686	Q8N2C7
NSRPAHNSTDLDPFK	TIAM2	1376	Q8IVF5
PKENFRKHSQPRSFD	RLF	1746	Q13129
EAKHPAFFTLPVVIN	SLC23A2	26	Q9UGH3
DPQDVRPSVFHNIKL	SLCO2B1	36	O94956
VSPILPEHHKDFNSQ	SPDYE16	71	A6NNV3
VSPILPEHHKDFNSQ	SPDYE18	111	P0DV79
VSPILPEHHKDFNSQ	SPDYE21	111	A0A494C086
VSPILPEHHKDFNSQ	SPDYE2	111	Q495Y8
SFLPGNQEDPHRFSK	PPM1M	401	Q96MI6
GRHKIPESQFPEFST	SRPK2	441	P78362
KFEIHFLQENTQPVP	TCTN1	361	Q2MV58
RKGLPPSHTQFDFVE	TENM4	481	Q6N022
EKQLPQSTLFRADHP	SERPINB7	346	O75635
AAPEPRFEHKVSNIF	WASHC2C	1296	Q9Y4E1
ALENDFFNSPPRKTV	RRN3P2	36	A6NIE6
PSLKVEPQNHFSSFK	TET3	1216	O43151
PILLSFENHVDSPKQ	PLCB1	406	Q9NQ66
DQPEKPHFDSRSVIF	TPGS2	131	Q68CL5
FRNLLSVGHPPFKQD	ZNF226	41	Q9NYT6
PQTPEQEKFLRHHFE	WDR62	1051	O43379
ARPFERKFESPKFNH	TJP1	1536	Q07157
RKFESPKFNHNLLPS	TJP1	1541	Q07157
QAAPEPRFEHKVSNI	WASHC2A	1316	Q641Q2
PRFEHKVSNIFDDPL	WASHC2A	1321	Q641Q2
SFFKQHLDSPENNKP	ZBED5	166	Q49AG3
SEPQKEPNFRNITHD	ZNF462	766	Q96JM2
VPRNAQFKPHTDEDL	WNT4	256	P56705
PTRDHKNPVIFGLFN	SEMA3E	316	O15041
VSPILPEHHKDFNSQ	nan	71	A6NJR5
LTFQPLHPAERKTQV	ZNF365	61	Q70YC4
LNVFSHAAELQPEKP	TTC16	156	Q8NEE8
HQFPAKPLRESQSHL	ZDHHC2	321	Q9UIJ5
HFNEKPNLALPEETF	ZNF597	276	Q96LX8
LFAHFIQPAAQKTPT	SMARCA5	101	O60264
DEQLQKRSIFPIHPS	VWA8	561	A3KMH1
LAQHFPKTTEENPIF	TBK1	366	Q9UHD2
KQFPRFSPHFAAELE	TLE6	41	Q9H808
KEKQHDIRSFFVPQP	ZRANB3	516	Q5FWF4
FNEVHAKRPQLPVSD	ZFHX3	1381	Q15911
PFHFDPKRAVQQLRA	MYO5B	666	Q9ULV0
QTDPAAVKLENFPIH	MYO9B	1751	Q13459
LPLHFFIQTVRPKDT	MYORG	141	Q6NSJ0